AMPICILLIN SODIUM Recall D-0600-2023
Description: Ampicillin and Sulbactam for Injection, USP 3 grams vials, Rx only, Mfg. for: Piramal Critical Care, Bethlehem, PA 18017 USA, NDC 66794-242-41
AMPICILLIN SODIUM Recall D-0600-2023 Information
Status | Ongoing |
Mandated? | Voluntary: Firm initiated |
Recall Number | D-0600-2023 |
Event ID | 92341 |
Brand | AMPICILLIN AND SULBACTAM |
Generic Name | AMPICILLIN AND SULBACTAM |
Manufacturer | AMPICILLIN AND SULBACTAM |
Original Package? | 1 |
Active Substance | AMPICILLIN SODIUM SULBACTAM SODIUM |
Drug Route | INTRAMUSCULAR |
Distribution | Nationwide within the United States |
Quantity | 91,860 vials |
Recall Reason | Lack of Assurance of Sterility |
Drug Classification | Class II |
Drug Code Info | 20230524 |
Product NDC | 66794-241 66794-242 |
Drug UPC | 0366794242027 0366794241020 |
Recall Initiation Date | 20230515 |
Report Date | 20230524 |
Classification Date | 20230518 |
Address | 911 G I D C Makarpura Vadodara, India |
Recalling Firm | Astral SteriTech Private Ltd. |
Initial Notification | Letter |
Unique Ingredient Identifier | JFN36L5S8K DKQ4T82YE6 |
Drug Application Number | ANDA090579 |
Structured Product Labeling (SPL ID) | f48ec7a8-42a6-88be-e053-2995a90ac849 |
Structured Product Labeling (SPL Set ID) | f48ecb78-1ca5-8c1f-e053-2a95a90a183d |
Similar To |